Levine Zurit
SEC CIK 1972527 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CGEN | COMPUGEN LTD | SVP, Business Development | 47.4K | — | $83.4K | 17 | 2026-03-26 | 2026-07-29 |
Most active insiders at CGEN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Levine Zurit | SVP, Business Development | — | $83.4K |
| 2 | Ophir Eran | Pres, CEO, Dir | — | $42.9K |
| 3 | Kredo Russo Sharon | SVP, Research, Discovery | — | — |
| 4 | Mahler Michelle | Chief Medical Off | — | — |
| 5 | Perry Eran | Dir | — | — |
| 6 | Halevy Gilead | Dir | — | — |
| 7 | Livnat Savitzky Kinneret | Dir | — | — |
| 8 | Hukkelhoven Mathias | Dir | — | — |
| 9 | Silberman David | CFO | — | — |
| 10 | ZWEIFACH SANFORD S | Dir | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-30 16:13 | 2026-07-29 | CGEN | COMPUGEN LTD | Levine Zurit | SVP, Business Development | A - Grant | $0.00 | +18.0K | 47.4K | +61% | $0 |
| DT | 2026-07-13 16:01 | 2026-07-09 | CGEN | COMPUGEN LTD | Levine Zurit | SVP, Business Development | M - OptEx | $0.8292 | +1,875 | 31.2K | +6% | +$1,555 |
| DT | 2026-07-13 16:01 | 2026-07-09 | CGEN | COMPUGEN LTD | Levine Zurit | SVP, Business Development | S - Sale+OE | $2.50 | -1,875 | 29.4K | -6% | -$4,688 |
| DT | 2026-04-27 16:03 | 2026-04-24 | CGEN | COMPUGEN LTD | Levine Zurit | SVP, Business Development | M - OptEx | $1.15 | +2,000 | 31.4K | +7% | +$2,300 |
| DT | 2026-04-27 16:03 | 2026-04-24 | CGEN | COMPUGEN LTD | Levine Zurit | SVP, Business Development | S - Sale+OE | $3.20 | -2,000 | 29.4K | -6% | -$6,400 |
| DT | 2026-04-15 16:07 | 2026-04-14 | CGEN | COMPUGEN LTD | Levine Zurit | SVP, Business Development | M - OptEx | $1.15 | +2,000 | 31.4K | +7% | +$2,300 |
| DT | 2026-04-15 16:07 | 2026-04-14 | CGEN | COMPUGEN LTD | Levine Zurit | SVP, Business Development | S - Sale+OE | $2.80 | -2,000 | 29.4K | -6% | -$5,600 |
| DMAT | 2026-04-15 16:03 | 2026-04-10 | CGEN | COMPUGEN LTD | Levine Zurit | SVP, Business Development | M - OptEx | $1.03 | +3,125 | 32.5K | +11% | +$3,233 |
| DAT | 2026-04-15 16:03 | 2026-04-10 | CGEN | COMPUGEN LTD | Levine Zurit | SVP, Business Development | S - Sale+OE | $2.56 | -3,125 | 29.4K | -10% | -$8,012 |
| DMT | 2026-04-13 16:04 | 2026-04-10 | CGEN | COMPUGEN LTD | Levine Zurit | SVP, Business Development | M - OptEx | $1.03 | +3,125 | 32.5K | +11% | +$3,233 |
| DT | 2026-04-13 16:04 | 2026-04-10 | CGEN | COMPUGEN LTD | Levine Zurit | SVP, Business Development | S - Sale+OE | $2.56 | -3,125 | 29.4K | -10% | -$8,012 |
| DMT | 2026-04-09 16:05 | 2026-04-07+ | CGEN | COMPUGEN LTD | Levine Zurit | SVP, Business Development | M - OptEx | $0.8699 | +7,875 | 34.8K | +29% | +$6,851 |
| DMT | 2026-04-09 16:05 | 2026-04-07+ | CGEN | COMPUGEN LTD | Levine Zurit | SVP, Business Development | S - Sale+OE | $2.38 | -7,875 | 29.4K | -21% | -$18.8K |
| DMT | 2026-04-03 07:31 | 2026-04-01 | CGEN | COMPUGEN LTD | Levine Zurit | SVP, Business Development | M - OptEx | $0.9209 | +3,500 | 32.9K | +12% | +$3,223 |
| DT | 2026-04-03 07:31 | 2026-04-01 | CGEN | COMPUGEN LTD | Levine Zurit | SVP, Business Development | S - Sale+OE | $2.20 | -3,500 | 29.4K | -11% | -$7,700 |
| D | 2026-03-30 | 2026-03-26 | CGEN | COMPUGEN LTD | Levine Zurit | SVP, Business Development | M - OptEx | $0.83 | +11.9K | 41.2K | +40% | +$9,856 |
| D | 2026-03-30 | 2026-03-26 | CGEN | COMPUGEN LTD | Levine Zurit | SVP, Business Development | S - Sale+OE | $2.04 | -11.9K | 29.4K | -29% | -$24.2K |
Purchase Sale Sale after option exercise All abbreviations